Oct 21 (Reuters) - Canadian generic-drug maker Concordia International Corp said on Friday that Chief Executive Mark Thompson would step down after a replacement is found.
A search process for a new CEO is underway, the company said.
Concordia’s Toronto-listed shares were halted after rising 27 percent to C$6.67. The company’s U.S.-listed shares were also halted. (Reporting by Anet Josline Pinto in Bengaluru; Editing by Anil D‘Silva)